Carson Wealth (CWM LLC)
ALDX icon

Carson Wealth (CWM LLC)’s Aldeyra Therapeutics ALDX Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$155K Buy
91,623
+48,318
+112% +$212K ﹤0.01% 2941
2025
Q4 		$224K Sell
43,305
-15,074
-26% -$77.4K ﹤0.01% 2476
2025
Q3 		$305K Buy
58,379
+16,621
+40% +$86.7K ﹤0.01% 2118
2025
Q2 		$160K Buy
41,758
+22,514
+117% +$58.2K ﹤0.01% 2363
2025
Q1 		$111K Buy
19,244
+17,722
+1,164% +$105K ﹤0.01% 2350
2024
Q4 		$8K Buy
1,522
+618
+68% +$3.17K ﹤0.01% 3962
2024
Q3 		$5K Buy
904
+165
+22% +$785 ﹤0.01% 4059
2024
Q2 		$2K Buy
739
+539
+270% +$2.11K ﹤0.01% 4152
2024
Q1 		$1K Buy
200
+9
+5% +$30 ﹤0.01% 4060
2023
Q4 		$1K Buy
+191
New +$589 ﹤0.01% 3884
2022
Q2 		– Sell
-39
Closed – – 3751
2022
Q1 		$0 Buy
+39
New +$155 ﹤0.01% 3496

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Carson Wealth (CWM LLC)'s ALDX Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Aldeyra Therapeutics (ALDX) stake by 112% in Q1 2026, buying an estimated $212K and bringing the position to 91,623 shares worth $155K. The position accounts for ﹤0.01% of the portfolio, ranked #2941.

Carson Wealth (CWM LLC) first reported a position in ALDX in Q1 2022 and has held it in 11 quarters since. The position peaked at $305K in Q3 2025. 126 funds tracked by Wall St. Rank hold ALDX as of Q1 2026.

  • Carson Wealth (CWM LLC) held 91,623 shares of Aldeyra Therapeutics worth $155K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 48,318 Aldeyra Therapeutics shares in Q1 2026, an estimated $212K.
  • Aldeyra Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #2941 holding.
  • Carson Wealth (CWM LLC) first reported a position in Aldeyra Therapeutics in Q1 2022 and has held it in 11 quarters since.
  • Carson Wealth (CWM LLC)'s Aldeyra Therapeutics position peaked at $305K in Q3 2025.
  • 126 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.